Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions:
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | English |
| Published: |
Baden-Baden
Nomos
2011
|
| Edition: | 1. edition |
| Series: | MIPLC studies
12 |
| Subjects: | |
| Online Access: | Volltext Inhaltsverzeichnis |
| Physical Description: | 75 S. |
| ISBN: | 9783832965242 |
| DOI: | 10.5771/9783845232188 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV037367985 | ||
| 003 | DE-604 | ||
| 005 | 20250211 | ||
| 007 | t| | ||
| 008 | 110427s2011 xx m||| 00||| eng d | ||
| 015 | |a 11,N15 |2 dnb | ||
| 016 | 7 | |a 1010890514 |2 DE-101 | |
| 020 | |a 9783832965242 |c Pb. : ca. EUR 19.90 (DE), ca. sfr 30.50 (freier Pr.) |9 978-3-8329-6524-2 | ||
| 024 | 3 | |a 9783832965242 | |
| 035 | |a (OCoLC)725076017 | ||
| 035 | |a (DE-599)DNB1010890514 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-355 |a DE-473 |a DE-859 |a DE-521 |a DE-634 |a DE-1051 |a DE-706 |a DE-739 |a DE-1046 |a DE-384 |a DE-860 |a DE-20 | ||
| 082 | 0 | |a 346.430486 |2 22/ger | |
| 084 | |a PU 1547 |0 (DE-625)139927: |2 rvk | ||
| 084 | |a 340 |2 sdnb | ||
| 100 | 1 | |a Ahn, Hyewon |e Verfasser |0 (DE-588)1052960936 |4 aut | |
| 245 | 1 | 0 | |a Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions |c Hyewon Ahn |
| 250 | |a 1. edition | ||
| 264 | 1 | |a Baden-Baden |b Nomos |c 2011 | |
| 300 | |a 75 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a MIPLC studies |v 12 | |
| 502 | |b Masterarbeit |c Munich Intellectual Property Law Center München |d 2010 | ||
| 650 | 0 | 7 | |a Enantiomere |0 (DE-588)4152130-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Patentfähigkeit |0 (DE-588)4173529-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirkstoff |0 (DE-588)4066383-8 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 0 | 1 | |a Patentfähigkeit |0 (DE-588)4173529-8 |D s |
| 689 | 0 | 2 | |a Enantiomere |0 (DE-588)4152130-4 |D s |
| 689 | 0 | 3 | |a Wirkstoff |0 (DE-588)4066383-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-8452-3218-8 |
| 830 | 0 | |a MIPLC studies |v 12 |w (DE-604)BV035044599 |9 12 | |
| 856 | 4 | 1 | |u http://doi.org/10.5771/9783845232188 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022521391&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 912 | |a ZDB-18-NEA | ||
| 912 | |a ZDB-1-NJU | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-022521391 | |
Record in the Search Index
| _version_ | 1823773634337964032 |
|---|---|
| adam_text |
IMAGE 1
TABLE OF CONTENTS
I. INTRODUCTION 11
II. BACKGROUND 17
A. MARKUSH TYPE CLAIM 17
B. ENANTIOMERS AND RELATED PATENTS 17
III. JURISPRUDENCE ON THE PATENTABILITY REQUIREMENTS FOR SELECTION
INVENTIONS 21
A. FACTS OF THE CASES 21
1. FACTS IN OLANZAPINE 21
2. FACTS IN ESCITALOPRAM 21
B. NOVELTY REQUIREMENT 22
1. FROM THE GERMAN PERSPECTIVE: "PARTING FROM FLUORAN" 22 A) MARKUSH
CLAIM - OLANZAPINE DECISION 23
(1) FEDERAL PATENT COURT DECISION 23
(2) FEDERAL COURT OF JUSTICE DECISION 24
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 26 (1) FEDERAL PATENT
COURT DECISION 26
(2) FEDERAL COURT OF JUSTICE DECISION 26
2. FROM THE U.S. PERSPECTIVE 27
A) MARKUSH CLAIM - OLANZAPINE DECISION 27
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 28 3. FROM THE UK
PERSPECTIVE: "PARTING FROM IG RULE" 28 A) MARKUSH CLAIM - OLANZAPINE
DECISION 29
(1) PATENT COURT DECISION 29
(2) COURT OF APPEAL DECISION 29
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 30 4. SUMMARY 31
C. NONOBVIOUSNESS REQUIREMENT 31
1. FROM THE GERMAN PERSPECTIVE 31
A) MARKUSH CLAIM - OLANZAPINE DECISION 31
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 33 2. FROM THE U.S.
PERSPECTIVE 33
A) MARKUSH CLAIM - OLANZAPINE DECISION 33
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 34
BIBLIOGRAFISCHE INFORMATIONEN HTTP://D-NB.INFO/1010890514
DIGITALISIERT DURCH
IMAGE 2
3. FROM THE UK PERSPECTIVE 35
A) MARKUSH CLAIM - OLANZAPINE DECISION 35
(1) PATENT COURT DECISION 35
(2) COURT OF APPEAL DECISION 36
B) ENANTIOMER INVENTION - ESCITALOPRAM DECISION 36 (1) COURT OF APPEAL
DECISION 36
(2) THE HOUSE OF LORDS DECISION 37
4. SUMMARY 37
D. SUMMARY AND CONCLUSION 38
IV. DISCUSSION 39
A. ANTICIPATION 39
1. RELATIVITY OF NOVELTY 39
2. ENABLEMENT AS A REQUIREMENT FOR ANTICIPATION 42
3. IMPLICATIONS OF ENABLEMENT REQUIREMENT IN ANTICIPATION 44 A) THE TEST
OF ANTICIPATION: PRECEDENT TEST OF OBVIOUSNESS? 44 B) A POSSIBLE GROUND
FOR CHALLENGING THE BASIC PATENT 45 C) OTHER IMPLICATIONS OF THE RULES
FOR DISCLOSURE IN THE
OLANZAPINE CASE 46
4. CONCLUSION 47
B. OBVIOUSNESS 48
1. PRIMA FACIE OBVIOUSNESS 48
A) SIZE OF THE GENUS 48
B) STRUCTURAL SIMILARITY 49
C) REASONABLE EXPECTATION OF SUCCESS 50
2. OVERCOMING OBVIOUSNESS 51
A) TEACH AWAY 51
B) UNEXPECTED RESULTS 51
C) OTHER SECONDARY CONSIDERATIONS 52
3. CONSIDERATIONS 52
A) PERSON SKILLED IN THE ART IN THE OLANZAPINE DECISION 52 B) REASONABLE
EXPECTATION OF SUCCESS: ESCITALOPRAM DECISION 53
4. CONCLUSION 54
C. IMPACT OF LOWERING THE BAR FOR THE PATENTABILITY OF SELECTION
INVENTIONS 54
1. EASIER EXTENSION OF EXCLUSIVE RIGHT: "EVERGREENING" OR "LIFE- CYCLE
MANAGEMENT" 55
2. MORE LIMITATIONS TO EXPLOITING SELECTION PATENTS 55
A) SCOPE OF A SELECTION INVENTION OVER A BASIC PATENT 55
IMAGE 3
B) POSSIBLE SOLUTIONS 57
(1) REVERSE DOCTRINE OF EQUIVALENCE 57
(2) PATENT ACT CONSIDERATION - COMPULSORY LICENSE 58 (3) COMPETITION LAW
CONSIDERATION - THE ORANGE BOOK STANDARD DECISION 60
C) CONCLUSION 61
D. DIFFERENT VIEW IN OTHER JURISDICTIONS 61
1. SELECTION INVENTIONS IN KOREA 61
A) CLOPIDOGREL DECISION 61
B) ATORVASTATIN DECISION 62
2. SELECTION INVENTIONS IN JAPAN 63
3. SUMMARY AND CONCLUSION 64
V. CONCLUSION 65
ABSTRACT 67
LIST OF WORKS CITED 69 |
| any_adam_object | 1 |
| author | Ahn, Hyewon |
| author_GND | (DE-588)1052960936 |
| author_facet | Ahn, Hyewon |
| author_role | aut |
| author_sort | Ahn, Hyewon |
| author_variant | h a ha |
| building | Verbundindex |
| bvnumber | BV037367985 |
| classification_rvk | PU 1547 |
| collection | ZDB-18-NEA ZDB-1-NJU |
| ctrlnum | (OCoLC)725076017 (DE-599)DNB1010890514 |
| dewey-full | 346.430486 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 346 - Private law |
| dewey-raw | 346.430486 |
| dewey-search | 346.430486 |
| dewey-sort | 3346.430486 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| doi_str_mv | 10.5771/9783845232188 |
| edition | 1. edition |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV037367985</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20250211</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">110427s2011 xx m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">11,N15</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1010890514</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783832965242</subfield><subfield code="c">Pb. : ca. EUR 19.90 (DE), ca. sfr 30.50 (freier Pr.)</subfield><subfield code="9">978-3-8329-6524-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783832965242</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)725076017</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1010890514</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-634</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.430486</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PU 1547</subfield><subfield code="0">(DE-625)139927:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">340</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ahn, Hyewon</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1052960936</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions</subfield><subfield code="c">Hyewon Ahn</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Baden-Baden</subfield><subfield code="b">Nomos</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">75 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">MIPLC studies</subfield><subfield code="v">12</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Masterarbeit</subfield><subfield code="c">Munich Intellectual Property Law Center München</subfield><subfield code="d">2010</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enantiomere</subfield><subfield code="0">(DE-588)4152130-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentfähigkeit</subfield><subfield code="0">(DE-588)4173529-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstoff</subfield><subfield code="0">(DE-588)4066383-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Patentfähigkeit</subfield><subfield code="0">(DE-588)4173529-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Enantiomere</subfield><subfield code="0">(DE-588)4152130-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Wirkstoff</subfield><subfield code="0">(DE-588)4066383-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-8452-3218-8</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">MIPLC studies</subfield><subfield code="v">12</subfield><subfield code="w">(DE-604)BV035044599</subfield><subfield code="9">12</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://doi.org/10.5771/9783845232188</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022521391&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-18-NEA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-NJU</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022521391</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| geographic | Deutschland (DE-588)4011882-4 gnd |
| geographic_facet | Deutschland |
| id | DE-604.BV037367985 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-11T15:01:13Z |
| institution | BVB |
| isbn | 9783832965242 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022521391 |
| oclc_num | 725076017 |
| open_access_boolean | 1 |
| owner | DE-M382 DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-739 DE-1046 DE-384 DE-860 DE-20 |
| owner_facet | DE-M382 DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-739 DE-1046 DE-384 DE-860 DE-20 |
| physical | 75 S. |
| psigel | ZDB-18-NEA ZDB-1-NJU |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Nomos |
| record_format | marc |
| series | MIPLC studies |
| series2 | MIPLC studies |
| spelling | Ahn, Hyewon Verfasser (DE-588)1052960936 aut Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions Hyewon Ahn 1. edition Baden-Baden Nomos 2011 75 S. txt rdacontent n rdamedia nc rdacarrier MIPLC studies 12 Masterarbeit Munich Intellectual Property Law Center München 2010 Enantiomere (DE-588)4152130-4 gnd rswk-swf Patentfähigkeit (DE-588)4173529-8 gnd rswk-swf Wirkstoff (DE-588)4066383-8 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Deutschland (DE-588)4011882-4 g Patentfähigkeit (DE-588)4173529-8 s Enantiomere (DE-588)4152130-4 s Wirkstoff (DE-588)4066383-8 s DE-604 Erscheint auch als Online-Ausgabe 978-3-8452-3218-8 MIPLC studies 12 (DE-604)BV035044599 12 http://doi.org/10.5771/9783845232188 Verlag kostenfrei Volltext DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022521391&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Ahn, Hyewon Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions MIPLC studies Enantiomere (DE-588)4152130-4 gnd Patentfähigkeit (DE-588)4173529-8 gnd Wirkstoff (DE-588)4066383-8 gnd |
| subject_GND | (DE-588)4152130-4 (DE-588)4173529-8 (DE-588)4066383-8 (DE-588)4011882-4 (DE-588)4113937-9 |
| title | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions |
| title_auth | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions |
| title_exact_search | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions |
| title_full | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions Hyewon Ahn |
| title_fullStr | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions Hyewon Ahn |
| title_full_unstemmed | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions Hyewon Ahn |
| title_short | Patentability of chemical selection inventions: The Olanzapine and Escitalopram Decisions |
| title_sort | patentability of chemical selection inventions the olanzapine and escitalopram decisions |
| topic | Enantiomere (DE-588)4152130-4 gnd Patentfähigkeit (DE-588)4173529-8 gnd Wirkstoff (DE-588)4066383-8 gnd |
| topic_facet | Enantiomere Patentfähigkeit Wirkstoff Deutschland Hochschulschrift |
| url | http://doi.org/10.5771/9783845232188 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022521391&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV035044599 |
| work_keys_str_mv | AT ahnhyewon patentabilityofchemicalselectioninventionstheolanzapineandescitalopramdecisions |